• Company
• Repurposed drugs for COVID-19 unveil clinical trial findings
• by Moon, sung-ho Mar 18, 2021 06:19am

• Company
• Lynparza, to be approved for prostate & pancreatic cancer
• by Eo, Yun-Ho Mar 17, 2021 06:10am

• Policy
• Alunbrig coverage granted for first-line lung cancer therapy
• by Lee, Hye-Kyung Mar 17, 2021 06:10am

• Company
• General hospitals to prescribe Dupixent for adolescents
• by Eo, Yun-Ho Mar 17, 2021 06:10am

• Policy
• PE guideline revised for the first time in 9 years
• by Lee, Hye-Kyung Mar 17, 2021 06:10am

• Company
• Yuhan to sell Samsung’s biosimilar for Humira in Korea
• by An, Kyung-Jin Mar 17, 2021 06:09am

• Company
• Praluent is in the process of listing insurance benefits
• by Eo, Yun-Ho Mar 17, 2021 06:09am

• Policy
• Voluntary withdrawal of benefit redemption excluding α-GPC
• by Lee, Hye-Kyung Mar 16, 2021 06:22am

• Company
• Takeda to chase Roche in ALK targeted therapy market
• by Mar 16, 2021 06:22am

• Company
• Binex is likely to be removed from the KPBMA member list
• by Nho, Byung Chul Mar 16, 2021 06:22am